Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission.

Reneman L, Booij J, Schmand B, van den Brink W, Gunning B.

Psychopharmacology (Berl). 2000 Feb;148(3):322-4.

PMID:
10755746
2.

Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.

Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M.

J Psychopharmacol. 2006 May;20(3):373-84.

PMID:
16574711
3.

The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain.

Reneman L, Endert E, de Bruin K, Lavalaye J, Feenstra MG, de Wolff FA, Booij J.

Neuropsychopharmacology. 2002 Mar;26(3):387-96.

4.

Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.

Reneman L, Schilt T, de Win MM, Booij J, Schmand B, van den Brink W, Bakker O.

J Psychopharmacol. 2006 May;20(3):389-99.

PMID:
16574713
5.

MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings.

Reneman L, Habraken JB, Majoie CB, Booij J, den Heeten GJ.

AJNR Am J Neuroradiol. 2000 Jun-Jul;21(6):1001-7.

6.

Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings.

Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J.

Arch Gen Psychiatry. 2001 Oct;58(10):901-6.

PMID:
11576026
7.

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.

Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.

J Psychopharmacol. 2006 Mar;20(2):211-25. Review.

PMID:
16510479
8.

Memory impairment in abstinent MDMA ("Ecstasy") users.

Bolla KI, McCann UD, Ricaurte GA.

Neurology. 1998 Dec;51(6):1532-7.

PMID:
9855498
9.

Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report.

Reneman L, Majoie CB, Schmand B, van den Brink W, den Heeten GJ.

Biol Psychiatry. 2001 Oct 1;50(7):550-4.

PMID:
11600108
10.

Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users.

McCann UD, Eligulashvili V, Mertl M, Murphy DL, Ricaurte GA.

Psychopharmacology (Berl). 1999 Nov;147(1):56-65.

PMID:
10591869
11.

Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study.

Cowan RL, Lyoo IK, Sung SM, Ahn KH, Kim MJ, Hwang J, Haga E, Vimal RL, Lukas SE, Renshaw PF.

Drug Alcohol Depend. 2003 Dec 11;72(3):225-35.

PMID:
14643939
12.

Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.

Gouzoulis-Mayfrank E, Fischermann T, Rezk M, Thimm B, Hensen G, Daumann J.

Drug Alcohol Depend. 2005 Jun 1;78(3):317-23. Epub 2005 Jan 19.

PMID:
15893163
13.

Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.

Reneman L, Majoie CB, Flick H, den Heeten GJ.

AJNR Am J Neuroradiol. 2002 Feb;23(2):231-7.

14.
15.

Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.

Urban NB, Girgis RR, Talbot PS, Kegeles LS, Xu X, Frankle WG, Hart CL, Slifstein M, Abi-Dargham A, Laruelle M.

Neuropsychopharmacology. 2012 May;37(6):1465-73. doi: 10.1038/npp.2011.332. Epub 2012 Feb 22.

16.

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users.

Semple DM, Ebmeier KP, Glabus MF, O'Carroll RE, Johnstone EC.

Br J Psychiatry. 1999 Jul;175:63-9.

PMID:
10621770
17.

Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').

Ricaurte GA, McCann UD, Szabo Z, Scheffel U.

Toxicol Lett. 2000 Mar 15;112-113:143-6. Review.

PMID:
10720723
18.

Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study.

McCann UD, Mertl M, Eligulashvili V, Ricaurte GA.

Psychopharmacology (Berl). 1999 Apr;143(4):417-25.

PMID:
10367560
19.

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA.

Lancet. 1998 Oct 31;352(9138):1433-7.

PMID:
9807990
20.

Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.

Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ.

J Psychopharmacol. 2006 Mar;20(2):164-75. Review.

PMID:
16510475

Supplemental Content

Support Center